Gender-affirming care may reduce the risk of HIV among trans, nonbinary and gender-diverse people
Gender-affirming hormone therapy (GAHT) is associated with significantly improved HIV outcomes for transgender, nonbinary, ...
LGBTQ Nation on MSN13d
Hormone therapy reduces depression in trans & nonbinary adults, new study says
A newly published study of 3,592 transgender, nonbinary, and gender-diverse (TGD) patients found that 15% of patients with ...
Scripps News on MSN20d
New study reveals gender-affirming hormone therapy reduces depression in transgender adults
Transgender adults face higher depression rates; a study demonstrates that hormone therapy may serve as a vital intervention in this vulnerable population.
MPR13d
Gender-Affirming Hormone Therapy in Primary Care Tied to Reduced Depressive Symptoms
HealthDay News — Gender-affirming hormone therapy (GAHT) in primary care is associated with lower rates of moderate-to-severe depressive symptoms in US transgender, nonbinary, and gender-diverse (TGD) ...
Hosted on MSN1mon
Study shows encouraging uptake and adherence to oral PrEP among transgender women
"Overall peer support and providing access to GAHT and other needed services in both study arms likely led to an increase in PrEP engagement among study participants, highlighting the critical ...